NCT07213700 · RECRUITING
InRAD Observational Study
This is an observational registry, not a treatment trial. Nothing is given to participants. Researchers collect real-world health information from people being evaluated for, or living with, Alzheimer's at clinics worldwide. They track long-term outcomes and how safe and useful existing treatments are over many years. No phase applies, since no new intervention is tested.
Eligibility criteria
Inclusion Criteria: * Be undergoing diagnostic work-up for Alzheimer's disease (AD), OR * Have a confirmed diagnosis of AD (whether currently treated with an AD-specific treatment, or untreated), * Be attending an InRAD Center, * Have provided informed consent for long-term follow-up Exclusion Criteria: -Any patient or legal representative who is unable or unwilling to provide a signed informed consent form The protocol does not specify a lower or upper age limit. Participants are expected to be predominantly adults, and can include younger adults with early-onset or genetically determined Alzheimer's disease (e.g. Down syndrome-associated Alzheimer's disease).
The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.
Eligibility criteria as of 2026-10-06